|
|
||||||||


* Department of Molecular Virology, Immunology, and Medical Genetics, Ohio State University, Columbus, OH 43210;
Department of Microbiology and Immunology, Virginia Commonwealth University, Richmond, VA 23298; and
Department of Immunology, Duke University Medical Center, Durham, NC 27710
Although the causes of asthma vary, the severity of the disease correlates with the level of IgE produced. In this study we show that mice produced less IgE when they were depleted of the neurotransmitter norepinephrine (NE) before the administration of Ag. The suppression was prevented when a
2-adrenergic receptor (
2AR)-selective agonist was administered, suggesting that NE stimulated the
2AR to regulate the level of an IgE response in vivo. Although the cell targeted by NE to produce this effect in vivo is unknown, we show in vitro that the level of IgE increased on a per cell basis without an effect on class switch recombination when NE stimulated the
2AR on a B cell directly. The
2AR-induced increase in IgE depended on p38 MAPK but not protein kinase A activation, was due to an increased rate of mature IgE mRNA transcription, and was lost when
2AR-deficient B cells were used. Also, CD23 transcription was increased in a p38 MAPK-dependent manner and resulted in an increased level of soluble CD23 (sCD23). The
2AR-induced increase in sCD23 was associated with IgE up-regulation and possibly interacted with CD21/CD19. Using B cells from respective knockout mice, data showed that the
2AR-induced increase in IgE depended on B cell expression of CD23, CD21, and CD19. These findings suggest that at least one mechanism by which endogenous B cell activity in vivo is regulated by NE involves stimulation of the
2AR on the B cell alone to increase the level of IgE produced in a p38 MAPK- and sCD23-dependent manner.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 This work was supported in part by National Institutes of Health Grants AI37326 and A147420 (to V.M.S.) and Deutsche Forschungsgemeinschaft Grant PO 801/1-1 (to G.P.).
2 Address correspondence and reprint requests to Dr. Virginia Sanders, Department of Molecular Virology, Immunology, and Medical Genetics, Ohio State University, 2194 Graves Hall, 333 West 10th Avenue, Columbus, OH 43210. E-mail address: sanders.302{at}osu.edu
3 Abbreviations used in this paper: BAL, bronchoalveolar lavage; AR, adrenergic receptor; ATF-2, activating transcription factor 2; BALT, bronchus-associated lymphatic tissue; CSR, class switch recombination; GC, germinal center; i.t., intratracheal(ly); mCD23, membrane-bound CD23; NE, norepinephrine; sCD23, soluble CD23; 6-OHDA, 6-hydroxydopamine; PKA, protein kinase.
This article has been cited by other articles:
![]() |
X. Liu, L. Ye, Y. Bai, H. Mojidi, N. E. Simister, and X. Zhu Activation of the JAK/STAT-1 Signaling Pathway by IFN-{gamma} Can Down-Regulate Functional Expression of the MHC Class I-Related Neonatal Fc Receptor for IgG J. Immunol., July 1, 2008; 181(1): 449 - 463. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ganguly, C. Grodzki, D. Sugden, M. Moller, S. Odom, P. Gaildrat, I. Gery, R. P. Siraganian, J. Rivera, and D. C. Klein Neural Adrenergic/Cyclic AMP Regulation of the Immunoglobulin E Receptor {alpha}-Subunit Expression in the Mammalian Pinealocyte: A NEUROENDOCRINE/IMMUNE RESPONSE LINK? J. Biol. Chem., November 9, 2007; 282(45): 32758 - 32764. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. W. Kin and V. M. Sanders CD86 Regulates IgG1 Production via a CD19-Dependent Mechanism J. Immunol., August 1, 2007; 179(3): 1516 - 1523. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |